Protein family
The protein has not catalytic activity
Protein sequence
Protein function
Catalytic activity
PDB | Resolution (Å) | PDB name |
---|---|---|
2B05 | 2.55 | Crystal Structure of 14-3-3 gamma in complex with a phosphoserine peptide |
3UZD | 1.86 | Crystal structure of 14-3-3 GAMMA |
4E2E | 2.25 | Crystal structure of a tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (YWHAG) from Homo sapiens at 2.25 A resolution |
4J6S | 3.08 | 14-3-3gamma complexed with the N-terminal sequence of tyrosine hydroxylase (residues 1-43) |
4O46 | 2.9 | 14-3-3-gamma in complex with influenza NS1 C-terminal tail phosphorylated at S228 |
5D3E | 2.75 | Crystal structure of human 14-3-3 gamma in complex with CFTR R-domain peptide pS768-pS795 |
6A5S | 2.099 | Structure of 14-3-3 gamma in complex with TFEB 14-3-3 binding motif |
6BYJ | 2.9 | Structure of human 14-3-3 gamma bound to O-GlcNAc peptide |
6BYL | 3.35 | Structure of 14-3-3 gamma bound to O-GlcNAcylated thr peptide |
6BZD | 2.67 | Structure of 14-3-3 gamma R57E mutant bound to GlcNAcylated peptide |
6FEL | 2.84 | Structure of 14-3-3 gamma in complex with CaMKK2 14-3-3 binding motif Ser511 |
6GKF | 2.598 | Structure of 14-3-3 gamma in complex with caspase-2 14-3-3 binding motif Ser139 |
6GKG | 2.847 | Structure of 14-3-3 gamma in complex with caspase-2 14-3-3 binding motif Ser164 |
6S9K | 1.6 | Structure of 14-3-3 gamma in complex with caspase-2 peptide containing 14-3-3 binding motif Ser139 and NLS |
6SAD | 2.753 | Structure of 14-3-3 gamma in complex with double phosphorylated caspase-2 peptide on Ser139 and Ser164 |
6Y4K | 3.0 | Crystal structure of human 14-3-3 gamma in complex with CaMKK2 14-3-3 binding motif Ser100 and Fusicoccin A |
6Y6B | 3.08 | Crystal structure of human 14-3-3 gamma in complex with CaMKK2 14-3-3 binding motif Ser100 and 16-OMe-Fusicoccin H |
6ZBT | 1.79949 | Structure of 14-3-3 gamma in complex with Nedd4-2 14-3-3 binding motif Ser342 |
6ZC9 | 1.89896 | Structure of 14-3-3 gamma in complex with Nedd4-2 14-3-3 binding motif Ser448 |
7A6R | 2.7 | Structure of 14-3-3 gamma in complex with DAPK2 peptide containing the 14-3-3 binding motif |
7A6Y | 2.5 | Structure of 14-3-3 gamma in complex with DAPK2 peptide stabilized by FC-A |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0032869 | cellular response to insulin stimulus |
Biological Process | GO:0006469 | negative regulation of protein kinase activity |
Biological Process | GO:0006605 | protein targeting |
Biological Process | GO:0045664 | regulation of neuron differentiation |
Biological Process | GO:0009966 | regulation of signal transduction |
Biological Process | GO:0048167 | regulation of synaptic plasticity |
Biological Process | GO:0007165 | signal transduction |
Molecular Function | GO:0003723 | RNA binding |
Molecular Function | GO:0042802 | identical protein binding |
Molecular Function | GO:0005159 | insulin-like growth factor receptor binding |
Molecular Function | GO:0019904 | protein domain specific binding |
Molecular Function | GO:0005080 | protein kinase C binding |
Molecular Function | GO:0008426 | protein kinase C inhibitor activity |
Molecular Function | GO:0030971 | receptor tyrosine kinase binding |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0070062 | extracellular exosome |
Cellular Component | GO:0005925 | focal adhesion |
Cellular Component | GO:0016020 | membrane |
Cellular Component | GO:0098793 | presynapse |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-111447 | Activation of BAD and translocation to mitochondria | Leaf | R-HSA-5357801 | Programmed Cell Death |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | Leaf | R-HSA-5653656 | Vesicle-mediated transport |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centrosome | Internal node | R-HSA-1640170 | Cell Cycle |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | Leaf | R-HSA-1852241 | Organelle biogenesis and maintenance |
R-HSA-5625740 | RHO GTPases activate PKNs | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-75035 | Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-8854518 | AURKA Activation by TPX2 | Leaf | R-HSA-1640170 | Cell Cycle |
R-HSA-9614399 | Regulation of localization of FOXO transcription factors | Leaf | R-HSA-74160 | Gene expression (Transcription) |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | Leaf | R-HSA-1643685 | Disease |
R-HSA-9755779 | SARS-CoV-2 targets host intracellular signalling and regulatory pathways | Leaf | R-HSA-1643685 | Disease |
Location | ECO term | Pubmed |
---|---|---|
Cytoplasm | ECO:0000250 |
HPO ID | HPO name |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000252 | Microcephaly |
HP:0000348 | High forehead |
HP:0000494 | Downslanted palpebral fissures |
HP:0000504 | Abnormality of vision |
HP:0000508 | Ptosis |
HP:0000546 | Retinal degeneration |
HP:0000639 | Nystagmus |
HP:0000648 | Optic atrophy |
HP:0000668 | Hypodontia |
HP:0000708 | Atypical behavior |
HP:0000717 | Autism |
HP:0000739 | Anxiety |
HP:0000750 | Delayed speech and language development |
HP:0001249 | Intellectual disability |
HP:0001250 | Seizure |
HP:0001251 | Ataxia |
HP:0001252 | Hypotonia |
HP:0001257 | Spasticity |
HP:0001263 | Global developmental delay |
HP:0001265 | Hyporeflexia |
HP:0001268 | Mental deterioration |
HP:0001273 | Abnormal corpus callosum morphology |
HP:0001290 | Generalized hypotonia |
HP:0001298 | Encephalopathy |
HP:0001315 | Reduced tendon reflexes |
HP:0001336 | Myoclonus |
HP:0001337 | Tremor |
HP:0001388 | Joint laxity |
HP:0001508 | Failure to thrive |
HP:0001558 | Decreased fetal movement |
HP:0002020 | Gastroesophageal reflux |
HP:0002059 | Cerebral atrophy |
HP:0002063 | Rigidity |
HP:0002121 | Generalized non-motor (absence) seizure |
HP:0002133 | Status epilepticus |
HP:0002136 | Broad-based gait |
HP:0002317 | Unsteady gait |
HP:0002345 | Action tremor |
HP:0002353 | EEG abnormality |
HP:0002355 | Difficulty walking |
HP:0002370 | Poor coordination |
HP:0002376 | Developmental regression |
HP:0002392 | EEG with polyspike wave complexes |
HP:0002421 | Poor head control |
HP:0002509 | Limb hypertonia |
HP:0002521 | Hypsarrhythmia |
HP:0002650 | Scoliosis |
HP:0003593 | Infantile onset |
HP:0004305 | Involuntary movements |
HP:0004322 | Short stature |
HP:0007018 | Attention deficit hyperactivity disorder |
HP:0008770 | Obsessive-compulsive trait |
HP:0010844 | EEG with multifocal slow activity |
HP:0011153 | Focal motor seizure |
HP:0011443 | Abnormality of coordination |
HP:0011968 | Feeding difficulties |
HP:0012444 | Brain atrophy |
HP:0012447 | Abnormal myelination |
HP:0012547 | Abnormal involuntary eye movements |
HP:0032794 | Myoclonic seizure |
HP:0100660 | Dyskinesia |
HP:0100710 | Impulsivity |
Disease name | MONDO ID | ICD10 | ICD10 chapter | OMIM | Orphanet |
---|---|---|---|---|---|
undetermined early-onset epileptic encephalopathy | MONDO:0018614 | G40 | chapter6, Diseases of the nervous system | Orphanet:442835 | |
developmental and epileptic encephalopathy, 56 | MONDO:0033365 | G40 | chapter6, Diseases of the nervous system | OMIM:617665 |